Shaomeng Wang

机构：University of Michigan, Michigan Medicine, Michigan Center for Translational Pathology, University of Colorado Cancer Center, U-M Rogel Cancer Center, University of Colorado Denver · ORCID：0000-0002-8782-6950

发表论文 990 篇 · 总被引 41803 次 · h-index 103

代表论文

• Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance (2024 · Cancer Cell · 被引 103)
• STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity (2025 · Nature · 被引 73)
• Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader (2024 · Journal of Medicinal Chemistry · 被引 28)
• Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα) (2024 · Journal of Medicinal Chemistry · 被引 27)
• Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression (2024 · Journal of Medicinal Chemistry · 被引 26)
• Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy (2025 · Nature Communications · 被引 24)